68 related articles for article (PubMed ID: 7576242)
1. Regulated expression of the retinoblastoma susceptibility gene in mammary carcinoma cells restores cyclin D1 expression and G1-phase control.
Gjetting T; Lukas J; Bartek J; Strauss M
Biol Chem Hoppe Seyler; 1995 Jul; 376(7):441-6. PubMed ID: 7576242
[TBL] [Abstract][Full Text] [Related]
2. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 and retinoblastoma gene expression in human breast carcinoma: correlation with tumour proliferation and oestrogen receptor status.
Jares P; Rey MJ; Fernández PL; Campo E; Nadal A; Muñoz M; Mallofré C; Muntané J; Nayach I; Estapé J; Cardesa A
J Pathol; 1997 Jun; 182(2):160-6. PubMed ID: 9274525
[TBL] [Abstract][Full Text] [Related]
4. The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes.
Spitkovsky D; Steiner P; Gopalkrishnan RV; Eilers M; Jansen-Dürr P
Oncogene; 1995 Jun; 10(12):2421-5. PubMed ID: 7784093
[TBL] [Abstract][Full Text] [Related]
5. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
Nielsen NH; Emdin SO; Cajander J; Landberg G
Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.
Lukas J; Aagaard L; Strauss M; Bartek J
Cancer Res; 1995 Nov; 55(21):4818-23. PubMed ID: 7585513
[TBL] [Abstract][Full Text] [Related]
7. Loss of Rb and Myc activation co-operate to suppress cyclin D1 and contribute to transformation.
Marhin WW; Hei YJ; Chen S; Jiang Z; Gallie BL; Phillips RA; Penn LZ
Oncogene; 1996 Jan; 12(1):43-52. PubMed ID: 8552398
[TBL] [Abstract][Full Text] [Related]
8. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E.
Sofer-Levi Y; Resnitzky D
Oncogene; 1996 Dec; 13(11):2431-7. PubMed ID: 8957085
[TBL] [Abstract][Full Text] [Related]
11. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms.
Horton LE; Qian Y; Templeton DJ
Cell Growth Differ; 1995 Apr; 6(4):395-407. PubMed ID: 7794807
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of cyclin D1 and the Rb tumor suppressor gene in c-K-ras transformed rat enterocytes.
Arber N; Sutter T; Miyake M; Kahn SM; Venkatraj VS; Sobrino A; Warburton D; Holt PR; Weinstein IB
Oncogene; 1996 May; 12(9):1903-8. PubMed ID: 8649851
[TBL] [Abstract][Full Text] [Related]
13. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
Oswald F; Lovec H; Möröy T; Lipp M
Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
[TBL] [Abstract][Full Text] [Related]
14. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 gene expression in human cervical neoplasia.
Nichols GE; Williams ME; Gaffey MJ; Stoler MH
Mod Pathol; 1996 Apr; 9(4):418-25. PubMed ID: 8729983
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cell cycle entry and G1 progression by CSF-1.
Roussel MF
Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
19. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands.
Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T
Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172
[TBL] [Abstract][Full Text] [Related]
20. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]